HCA Healthcare, Inc. (NYSE:HCA) Insider Erol R. Akdamar Sells 2,900 Shares

HCA Healthcare, Inc. (NYSE:HCA) insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the sale, the insider now owns 6,843 shares in the company, valued at $2,415,579. This trade represents a 29.76 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

HCA Healthcare Stock Down 1.1 %

NYSE:HCA traded down $3.96 during mid-day trading on Thursday, reaching $345.36. The stock had a trading volume of 1,835,701 shares, compared to its average volume of 1,183,271. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The stock’s 50 day simple moving average is $387.05 and its two-hundred day simple moving average is $357.11. HCA Healthcare, Inc. has a 1-year low of $237.57 and a 1-year high of $417.14. The company has a market capitalization of $87.48 billion, a price-to-earnings ratio of 15.79, a price-to-earnings-growth ratio of 1.35 and a beta of 1.68.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be paid a $0.66 dividend. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.76%. HCA Healthcare’s payout ratio is currently 11.85%.

Analysts Set New Price Targets

Several research firms have recently issued reports on HCA. Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Truist Financial raised their price objective on HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. Barclays reduced their target price on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a report on Friday, November 8th. UBS Group lifted their target price on HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a report on Wednesday, August 14th. Finally, Morgan Stanley started coverage on HCA Healthcare in a report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 target price on the stock. Five equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $385.00.

Hedge Funds Weigh In On HCA Healthcare

A number of hedge funds and other institutional investors have recently bought and sold shares of HCA. CreativeOne Wealth LLC acquired a new position in shares of HCA Healthcare during the first quarter worth approximately $231,000. Bessemer Group Inc. raised its holdings in HCA Healthcare by 51.2% during the first quarter. Bessemer Group Inc. now owns 7,629 shares of the company’s stock worth $2,543,000 after purchasing an additional 2,584 shares in the last quarter. Swedbank AB bought a new stake in HCA Healthcare during the first quarter worth approximately $95,882,000. EP Wealth Advisors LLC raised its holdings in HCA Healthcare by 1.6% during the second quarter. EP Wealth Advisors LLC now owns 225,146 shares of the company’s stock worth $72,335,000 after purchasing an additional 3,516 shares in the last quarter. Finally, AustralianSuper Pty Ltd raised its holdings in HCA Healthcare by 118.5% during the third quarter. AustralianSuper Pty Ltd now owns 35,493 shares of the company’s stock worth $14,425,000 after purchasing an additional 19,247 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.